Using beetroot juice to prevent kidney damage during heart procedures
Official title: Suplementación Con Zumo de REmolacha Para Prevenir la Nefropatía Asociada a Contraste Durante la hospitalización Por Síndrome Coronario Agudo Sin elevación Del ST
Run by Hospital General Universitario Santa Lucia · NCT06695429 · Data updated 2026-11-12
This study is testing if drinking beetroot juice can help protect the kidneys of patients at high risk for kidney damage during heart procedures.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 130 (estimated) |
| Sponsor | Hospital General Universitario Santa Lucia Academic / other |
| Locations | 1 site (Cartagena) |
| Status | Recruiting |
| Started | October 7, 2024 |
| Main results expected | September 30, 2026 |
| Study ends | September 30, 2027 |
| Registry record updated | May 18, 2025 |
| Trial ID | NCT06695429 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults diagnosed with non-ST elevation acute coronary syndrome who are at moderate to high risk for contrast-induced nephropathy.
✕Probably not a fit
Patients with persistent ST segment elevation acute coronary syndrome or those on dialysis may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of beetroot juice supplementation in preventing contrast-induced nephropathy in patients hospitalized for non-ST elevation acute coronary syndrome who are at high risk for kidney injury. Participants will be divided into two groups: one receiving beetroot juice along with standard care, and the other receiving standard care alone. The intervention involves consuming 500 mL of beetroot juice daily for seven days or until discharge, while both groups will receive additional therapies to prevent kidney damage if needed. The study seeks to determine if the inorganic nitrates in beetroot juice can protect kidney function during cardiac catheterizations.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the incidence of kidney damage in patients undergoing heart procedures.
How similar studies have gone: Previous studies have shown promising results with inorganic nitrates in preventing contrast-induced nephropathy, but this specific approach using beetroot juice is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of Acute Coronary Syndrome without persistent ST segment elevation, with recommendation for invasive management according to the actual Clinical practice guidelines * At least moderate or high risk of nephropathy associated with iodinated contrast (Mehran score (without including contrast volume) ≥ 6). Exclusion Criteria: * \<18 years old or without capacity to give consent. * Refusal to participate in the study. * Known hypersensitivity to beetroot or any of its allergens. * Pregnant. * Inability to take food orally * Serious illnesses (not related to ACS or kidney failure), which limits their life expectancy to a period predictably less than 1 year. * On dialysis or predialysis at the time of inclusion. * ACS with persistent ST segment elevation before inclusion. * Shock or inotrope dependence at the time of inclusion * PCI already performed before inclusion. * Patients receiving intravenous nitroglycerin for \> 1 hour before inclusion
Where it's running
-
Hospital Universitario Santa Lucía
Cartagena, Spain Recruiting
Study contacts
- Study coordinator: Jose Manuel Andreu Cayuelas, PhD
- Email: jmandreu@msn.com
- Phone: +34 968 12 86 00
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Oral versus IV hydration to prevent contrast-related kidney injury after CT in the ER
This trial will test whether drinking water works as well as intravenous saline to prevent contrast-related kidney injury in adults with reduced kidney function who need a contrast CT in the emergency department.
-
Prehospital triage for intermediate- to high-risk NSTE-ACS using HEAR score and hs troponin
This trial tests whether directing certain intermediate- to high-risk chest-pain patients straight to a PCI center can be faster and cost-effective while not increasing major heart events.
-
Evaluating the impact of angiography-based FFR after heart procedures
This study is trying to see if measuring blood flow in heart arteries after a heart procedure can help predict serious heart problems and improve patients' quality of life.
-
Using magnetocardiography to identify heart ischemia in patients with suspected NSTE-ACS
This study is testing if a new heart scan using magnetocardiography can quickly and accurately find heart problems in people with chest pain suspected of having a type of heart attack.
-
Early Initiation of PCSK9 Inhibitor Tafolecimab in ACS Patients Undergoing PCI
This trial tests starting Tafolecimab early in people with acute coronary syndrome who are having PCI to lower bad cholesterol quickly and see if it reduces heart problems after discharge.
-
Comparing IV and oral hydration to prevent kidney injury after CT scans in severe kidney disease patients
This study is testing whether drinking fluids can be just as good as getting IV fluids to help prevent kidney injury in patients with severe kidney disease who are having a CT scan.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.